PDB Short entry for 2IPU HEADER IMMUNE SYSTEM 12-OCT-06 2IPU TITLE PFA1 FAB FRAGMENT COMPLEXED WITH ABETA 1-8 PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: IGG2A FAB FRAGMENT HEAVY CHAIN; COMPND 3 CHAIN: L, K; COMPND 4 MOL_ID: 2; COMPND 5 MOLECULE: IGG2A FAB FRAGMENT LIGHT CHAIN KAPPA; COMPND 6 CHAIN: H, G; COMPND 7 MOL_ID: 3; COMPND 8 MOLECULE: ABETA 1-8 PEPTIDE; COMPND 9 CHAIN: P, Q; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 STRAIN: BALB/C; SOURCE 6 OTHER_DETAILS: HYBRIDOMA; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 9 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 10 ORGANISM_TAXID: 10090; SOURCE 11 STRAIN: BALB/C; SOURCE 12 OTHER_DETAILS: HYBRIDOMA; SOURCE 13 MOL_ID: 3; SOURCE 14 SYNTHETIC: YES; SOURCE 15 OTHER_DETAILS: THIS SEQUENCE OCCURS NATURALLY IN HOMO SAPIENS SOURCE 16 (HUMANS) KEYWDS WWDDD, CDR, ABETA, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR A.S.GARDBERG,C.DEALWIS REVDAT 4 30-AUG-23 2IPU 1 REMARK SHEET LINK REVDAT 3 13-JUL-11 2IPU 1 VERSN REVDAT 2 24-FEB-09 2IPU 1 VERSN REVDAT 1 09-OCT-07 2IPU 0 JRNL AUTH A.S.GARDBERG,L.T.DICE,S.OU,R.L.RICH,E.HELMBRECHT,J.KO, JRNL AUTH 2 R.WETZEL,D.G.MYSZKA,P.H.PATTERSON,C.DEALWIS JRNL TITL MOLECULAR BASIS FOR PASSIVE IMMUNOTHERAPY OF ALZHEIMER'S JRNL TITL 2 DISEASE JRNL REF PROC.NATL.ACAD.SCI.USA V. 104 15659 2007 JRNL REFN ISSN 0027-8424 JRNL PMID 17895381 JRNL DOI 10.1073/PNAS.0705888104 REMARK 2 REMARK 2 RESOLUTION. 1.65 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.65 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 23.53 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 90.5 REMARK 3 NUMBER OF REFLECTIONS : 90407 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.184 REMARK 3 R VALUE (WORKING SET) : 0.182 REMARK 3 FREE R VALUE : 0.225 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 4515 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.65 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.69 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4083 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 58.59 REMARK 3 BIN R VALUE (WORKING SET) : 0.3250 REMARK 3 BIN FREE R VALUE SET COUNT : 206 REMARK 3 BIN FREE R VALUE : 0.3630 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6846 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 48 REMARK 3 SOLVENT ATOMS : 118 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 14.36 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.25000 REMARK 3 B22 (A**2) : -0.01000 REMARK 3 B33 (A**2) : 0.10000 REMARK 3 B12 (A**2) : 0.01000 REMARK 3 B13 (A**2) : 0.20000 REMARK 3 B23 (A**2) : -0.59000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.120 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.118 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.073 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.106 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.962 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.944 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 7230 ; 0.012 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 4840 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 9898 ; 1.436 ; 1.955 REMARK 3 BOND ANGLES OTHERS (DEGREES): 11887 ; 0.876 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 954 ; 6.564 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 275 ;33.330 ;23.818 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1155 ;13.138 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 33 ;18.750 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1125 ; 0.087 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 8056 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1445 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1106 ; 0.188 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 4918 ; 0.200 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 3353 ; 0.174 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 3916 ; 0.085 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 533 ; 0.134 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 29 ; 0.170 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 95 ; 0.252 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 74 ; 0.146 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 5871 ; 1.045 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1835 ; 0.192 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 7438 ; 1.234 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 3178 ; 1.954 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2426 ; 2.613 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2IPU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 21-OCT-06. REMARK 100 THE DEPOSITION ID IS D_1000039867. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-APR-06 REMARK 200 TEMPERATURE (KELVIN) : 113 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 90408 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.650 REMARK 200 RESOLUTION RANGE LOW (A) : 23.530 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.7 REMARK 200 DATA REDUNDANCY : 3.100 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05500 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.65 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.71 REMARK 200 COMPLETENESS FOR SHELL (%) : 66.3 REMARK 200 DATA REDUNDANCY IN SHELL : 2.90 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.46700 REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 2IQ9 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.29 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.17 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M TRIS, 25% PEG3350, PH 8.5, VAPOR REMARK 280 DIFFUSION, TEMPERATURE 294K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS A HETERODIMER WITH ABETA PEPTIDE REMARK 300 AT THE INTERFACE. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: L, H, Q REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: K, G, P REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY H 130 REMARK 465 THR H 131 REMARK 465 THR H 132 REMARK 465 GLY G 129 REMARK 465 GLY G 130 REMARK 465 THR G 131 REMARK 465 THR G 132 REMARK 465 GLY G 214 REMARK 465 PRO G 215 REMARK 465 THR G 216 REMARK 465 ASP P 1 REMARK 465 ASP Q 1 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN H 1 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL L 51 -49.19 74.38 REMARK 500 ASN L 189 -45.82 -132.74 REMARK 500 SER H 15 -13.76 78.66 REMARK 500 ASP H 55 -3.94 77.40 REMARK 500 SER H 172 -118.54 42.60 REMARK 500 SER H 172 -121.06 46.73 REMARK 500 VAL K 51 -50.35 75.14 REMARK 500 SER K 52 13.04 -140.73 REMARK 500 ALA K 129 77.57 -159.20 REMARK 500 SER G 15 -16.67 85.71 REMARK 500 SER G 15 -15.32 84.63 REMARK 500 ASP G 55 -6.69 80.54 REMARK 500 SER G 172 -121.98 62.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 615 REMARK 615 ZERO OCCUPANCY ATOM REMARK 615 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 615 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 615 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 615 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 615 M RES C SSEQI REMARK 615 HOH K 999 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACM L 1219 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACM H 1138 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACM K 1219 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL L 907 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL L 909 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL L 911 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL K 901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL K 903 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL K 905 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2IPT RELATED DB: PDB REMARK 900 PFA1 FAB FRAGMENT REMARK 900 RELATED ID: 2IQ9 RELATED DB: PDB REMARK 900 PFA2 FAB FRAGMENT, TRICLINIC APO FORM REMARK 900 RELATED ID: 2IQA RELATED DB: PDB REMARK 900 PFA2 FAB FRAGMENT, MONOCLINIC APO FORM REMARK 900 RELATED ID: 2IQB RELATED DB: PDB REMARK 900 PFA2 FAB FRAGMENT BOUND TO ABETA 1-8 REMARK 999 REMARK 999 SEQUENCE REMARK 999 PRESENTLY, THERE IS NO AMINOACID SEQUENCE DATABASE REMARK 999 REFERENCE AVAILABLE FOR THE TWO PROTEINS IGG2A FAB REMARK 999 FRAGMENT HEAVY CHAIN AND IGG2A FAB FRAGMENT LIGHT CHAIN REMARK 999 KAPPA DBREF 2IPU L 1 213 PDB 2IPU 2IPU 1 213 DBREF 2IPU H 1 216 PDB 2IPU 2IPU 1 216 DBREF 2IPU K 1 213 PDB 2IPU 2IPU 1 213 DBREF 2IPU G 1 216 PDB 2IPU 2IPU 1 216 DBREF 2IPU P 1 8 PDB 2IPU 2IPU 1 8 DBREF 2IPU Q 1 8 PDB 2IPU 2IPU 1 8 SEQRES 1 L 219 ASP VAL LEU MET THR GLN THR PRO LEU SER LEU PRO VAL SEQRES 2 L 219 SER LEU GLY ASP GLN ALA SER ILE SER CYS ARG SER SER SEQRES 3 L 219 GLN SER ILE VAL HIS SER ASN GLY ASN THR TYR LEU GLU SEQRES 4 L 219 TRP TYR LEU GLN LYS PRO GLY GLN SER PRO LYS LEU LEU SEQRES 5 L 219 ILE TYR LYS VAL SER ASN ARG PHE SER GLY VAL PRO ASP SEQRES 6 L 219 ARG PHE SER GLY SER GLY SER GLY THR ASP PHE THR LEU SEQRES 7 L 219 LYS ILE SER ARG VAL GLU ALA GLU ASP LEU GLY VAL TYR SEQRES 8 L 219 TYR CYS PHE GLN GLY SER HIS VAL PRO LEU THR PHE GLY SEQRES 9 L 219 ALA GLY THR LYS LEU GLU LEU LYS ARG ALA ASP ALA ALA SEQRES 10 L 219 PRO THR VAL SER ILE PHE PRO PRO SER SER GLU GLN LEU SEQRES 11 L 219 THR SER GLY GLY ALA SER VAL VAL CYS PHE LEU ASN ASN SEQRES 12 L 219 PHE TYR PRO LYS ASP ILE ASN VAL LYS TRP LYS ILE ASP SEQRES 13 L 219 GLY SER GLU ARG GLN ASN GLY VAL LEU ASN SER TRP THR SEQRES 14 L 219 ASP GLN ASP SER LYS ASP SER THR TYR SER MET SER SER SEQRES 15 L 219 THR LEU THR LEU THR LYS ASP GLU TYR GLU ARG HIS ASN SEQRES 16 L 219 SER TYR THR CYS GLU ALA THR HIS LYS THR SER THR SER SEQRES 17 L 219 PRO ILE VAL LYS SER PHE ASN ARG ASN GLU CYS SEQRES 1 H 226 GLN VAL THR LEU LYS GLU SER GLY PRO GLY ILE LEU LYS SEQRES 2 H 226 PRO SER GLN THR LEU SER LEU THR CYS SER PHE SER GLY SEQRES 3 H 226 PHE SER LEU SER THR SER GLY MET GLY VAL GLY TRP ILE SEQRES 4 H 226 ARG GLN PRO SER GLY LYS GLY LEU GLU TRP LEU ALA HIS SEQRES 5 H 226 ILE TRP TRP ASP ASP ASP ARG SER TYR ASN PRO SER LEU SEQRES 6 H 226 LYS SER GLN LEU THR ILE SER LYS ASP ALA ALA ARG ASN SEQRES 7 H 226 GLN VAL PHE LEU ARG ILE THR SER VAL ASP THR ALA ASP SEQRES 8 H 226 THR ALA THR TYR TYR CYS VAL ARG ARG ALA HIS THR THR SEQRES 9 H 226 VAL LEU GLY ASP TRP PHE ALA TYR TRP GLY GLN GLY THR SEQRES 10 H 226 LEU VAL THR VAL SER ALA ALA LYS THR THR ALA PRO SER SEQRES 11 H 226 VAL TYR PRO LEU ALA PRO VAL CYS GLY GLY THR THR GLY SEQRES 12 H 226 SER SER VAL THR LEU GLY CYS LEU VAL LYS GLY TYR PHE SEQRES 13 H 226 PRO GLU PRO VAL THR LEU THR TRP ASN SER GLY SER LEU SEQRES 14 H 226 SER SER GLY VAL HIS THR PHE PRO ALA VAL LEU GLN SER SEQRES 15 H 226 GLY LEU TYR THR LEU SER SER SER VAL THR VAL THR SER SEQRES 16 H 226 SER THR TRP PRO SER GLN SER ILE THR CYS ASN VAL ALA SEQRES 17 H 226 HIS PRO ALA SER SER THR LYS VAL ASP LYS LYS ILE GLU SEQRES 18 H 226 PRO ARG GLY PRO THR SEQRES 1 K 219 ASP VAL LEU MET THR GLN THR PRO LEU SER LEU PRO VAL SEQRES 2 K 219 SER LEU GLY ASP GLN ALA SER ILE SER CYS ARG SER SER SEQRES 3 K 219 GLN SER ILE VAL HIS SER ASN GLY ASN THR TYR LEU GLU SEQRES 4 K 219 TRP TYR LEU GLN LYS PRO GLY GLN SER PRO LYS LEU LEU SEQRES 5 K 219 ILE TYR LYS VAL SER ASN ARG PHE SER GLY VAL PRO ASP SEQRES 6 K 219 ARG PHE SER GLY SER GLY SER GLY THR ASP PHE THR LEU SEQRES 7 K 219 LYS ILE SER ARG VAL GLU ALA GLU ASP LEU GLY VAL TYR SEQRES 8 K 219 TYR CYS PHE GLN GLY SER HIS VAL PRO LEU THR PHE GLY SEQRES 9 K 219 ALA GLY THR LYS LEU GLU LEU LYS ARG ALA ASP ALA ALA SEQRES 10 K 219 PRO THR VAL SER ILE PHE PRO PRO SER SER GLU GLN LEU SEQRES 11 K 219 THR SER GLY GLY ALA SER VAL VAL CYS PHE LEU ASN ASN SEQRES 12 K 219 PHE TYR PRO LYS ASP ILE ASN VAL LYS TRP LYS ILE ASP SEQRES 13 K 219 GLY SER GLU ARG GLN ASN GLY VAL LEU ASN SER TRP THR SEQRES 14 K 219 ASP GLN ASP SER LYS ASP SER THR TYR SER MET SER SER SEQRES 15 K 219 THR LEU THR LEU THR LYS ASP GLU TYR GLU ARG HIS ASN SEQRES 16 K 219 SER TYR THR CYS GLU ALA THR HIS LYS THR SER THR SER SEQRES 17 K 219 PRO ILE VAL LYS SER PHE ASN ARG ASN GLU CYS SEQRES 1 G 226 GLN VAL THR LEU LYS GLU SER GLY PRO GLY ILE LEU LYS SEQRES 2 G 226 PRO SER GLN THR LEU SER LEU THR CYS SER PHE SER GLY SEQRES 3 G 226 PHE SER LEU SER THR SER GLY MET GLY VAL GLY TRP ILE SEQRES 4 G 226 ARG GLN PRO SER GLY LYS GLY LEU GLU TRP LEU ALA HIS SEQRES 5 G 226 ILE TRP TRP ASP ASP ASP ARG SER TYR ASN PRO SER LEU SEQRES 6 G 226 LYS SER GLN LEU THR ILE SER LYS ASP ALA ALA ARG ASN SEQRES 7 G 226 GLN VAL PHE LEU ARG ILE THR SER VAL ASP THR ALA ASP SEQRES 8 G 226 THR ALA THR TYR TYR CYS VAL ARG ARG ALA HIS THR THR SEQRES 9 G 226 VAL LEU GLY ASP TRP PHE ALA TYR TRP GLY GLN GLY THR SEQRES 10 G 226 LEU VAL THR VAL SER ALA ALA LYS THR THR ALA PRO SER SEQRES 11 G 226 VAL TYR PRO LEU ALA PRO VAL CYS GLY GLY THR THR GLY SEQRES 12 G 226 SER SER VAL THR LEU GLY CYS LEU VAL LYS GLY TYR PHE SEQRES 13 G 226 PRO GLU PRO VAL THR LEU THR TRP ASN SER GLY SER LEU SEQRES 14 G 226 SER SER GLY VAL HIS THR PHE PRO ALA VAL LEU GLN SER SEQRES 15 G 226 GLY LEU TYR THR LEU SER SER SER VAL THR VAL THR SER SEQRES 16 G 226 SER THR TRP PRO SER GLN SER ILE THR CYS ASN VAL ALA SEQRES 17 G 226 HIS PRO ALA SER SER THR LYS VAL ASP LYS LYS ILE GLU SEQRES 18 G 226 PRO ARG GLY PRO THR SEQRES 1 P 8 ASP ALA GLU PHE ARG HIS ASP SER SEQRES 1 Q 8 ASP ALA GLU PHE ARG HIS ASP SER HET ACM L1219 4 HET GOL L 907 6 HET GOL L 909 6 HET GOL L 911 6 HET ACM H1138 4 HET ACM K1219 4 HET GOL K 901 6 HET GOL K 903 6 HET GOL K 905 6 HETNAM ACM ACETAMIDE HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 7 ACM 3(C2 H5 N O) FORMUL 8 GOL 6(C3 H8 O3) FORMUL 16 HOH *118(H2 O) HELIX 1 1 GLU L 79 LEU L 83 5 5 HELIX 2 2 SER L 120 SER L 126 1 7 HELIX 3 3 LYS L 182 HIS L 188 1 7 HELIX 4 4 ASN L 211 CYS L 213 5 3 HELIX 5 5 PRO H 61 LYS H 64 5 4 HELIX 6 6 ALA H 73 ARG H 75 5 3 HELIX 7 7 ASP H 83 THR H 87 5 5 HELIX 8 8 SER H 156 SER H 158 5 3 HELIX 9 9 PRO H 200 SER H 203 5 4 HELIX 10 10 GLU K 79 LEU K 83 5 5 HELIX 11 11 SER K 120 SER K 126 1 7 HELIX 12 12 LYS K 182 GLU K 186 1 5 HELIX 13 13 ASN K 211 CYS K 213 5 3 HELIX 14 14 PRO G 61 LYS G 64 5 4 HELIX 15 15 ALA G 73 ARG G 75 5 3 HELIX 16 16 ASP G 83 THR G 87 5 5 HELIX 17 17 SER G 156 SER G 158 5 3 HELIX 18 18 PRO G 200 SER G 203 5 4 SHEET 1 A 2 MET L 4 THR L 7 0 SHEET 2 A 2 ALA L 19 SER L 25 -1 O ARG L 24 N THR L 5 SHEET 1 B 1 SER L 10 VAL L 13 0 SHEET 1 C 1 SER L 10 VAL L 13 0 SHEET 1 F 2 THR H 3 SER H 7 0 SHEET 2 F 2 LEU H 18 SER H 25 -1 O THR H 21 N SER H 7 SHEET 1 G 2 ILE H 11 LEU H 12 0 SHEET 2 G 2 THR H 117 VAL H 121 1 SHEET 1 K 2 MET K 4 THR K 7 0 SHEET 2 K 2 ALA K 19 SER K 25 -1 O ARG K 24 N THR K 5 SHEET 1 L 1 SER K 10 VAL K 13 0 SHEET 1 M 1 SER K 10 VAL K 13 0 SHEET 1 P 2 THR G 3 SER G 7 0 SHEET 2 P 2 LEU G 18 SER G 25 -1 O SER G 23 N LYS G 5 SHEET 1 Q 2 ILE G 11 LEU G 12 0 SHEET 2 Q 2 THR G 117 VAL G 121 1 SSBOND 1 CYS L 23 CYS L 88 1555 1555 2.06 SSBOND 2 CYS L 133 CYS L 193 1555 1555 2.01 SSBOND 3 CYS H 22 CYS H 92 1555 1555 2.02 SSBOND 4 CYS H 140 CYS H 195 1555 1555 2.05 SSBOND 5 CYS K 23 CYS K 88 1555 1555 2.08 SSBOND 6 CYS K 133 CYS K 193 1555 1555 2.05 SSBOND 7 CYS G 22 CYS G 92 1555 1555 2.03 SSBOND 8 CYS G 140 CYS G 195 1555 1555 2.03 LINK SG CYS L 213 C2 ACM L1219 1555 1555 1.77 LINK SG CYS H 128 C2 ACM H1138 1555 1555 1.77 LINK SG CYS K 213 C2 ACM K1219 1555 1555 1.77 CISPEP 1 THR L 7 PRO L 8 0 -8.49 CISPEP 2 VAL L 94 PRO L 95 0 1.05 CISPEP 3 TYR L 139 PRO L 140 0 -0.46 CISPEP 4 PHE H 146 PRO H 147 0 -6.48 CISPEP 5 GLU H 148 PRO H 149 0 -4.08 CISPEP 6 TRP H 188 PRO H 189 0 7.43 CISPEP 7 THR K 7 PRO K 8 0 -6.12 CISPEP 8 VAL K 94 PRO K 95 0 1.24 CISPEP 9 TYR K 139 PRO K 140 0 4.74 CISPEP 10 PHE G 146 PRO G 147 0 -7.83 CISPEP 11 GLU G 148 PRO G 149 0 -2.81 CISPEP 12 TRP G 188 PRO G 189 0 7.40 SITE 1 AC1 6 VAL H 127 CYS H 128 PRO L 118 ASN L 209 SITE 2 AC1 6 GLU L 212 CYS L 213 SITE 1 AC2 6 CYS H 128 GLY H 214 PRO H 215 ASP K 60 SITE 2 AC2 6 GLU L 212 CYS L 213 SITE 1 AC3 5 VAL G 127 PRO K 118 ASN K 209 GLU K 212 SITE 2 AC3 5 CYS K 213 SITE 1 AC4 6 THR H 176 SER H 178 LEU L 159 SER L 175 SITE 2 AC4 6 SER L 176 THR L 177 SITE 1 AC5 5 PRO L 59 ARG L 61 PHE L 62 GLU L 81 SITE 2 AC5 5 ASP L 82 SITE 1 AC6 3 SER L 121 GLU L 122 THR L 125 SITE 1 AC7 6 LEU K 37 LYS K 45 PRO K 59 PHE K 62 SITE 2 AC7 6 GLU K 81 ASP K 82 SITE 1 AC8 5 ALA H 201 SER H 202 VAL K 51 GLY K 66 SITE 2 AC8 5 ARG L 187 SITE 1 AC9 5 ALA G 201 SER G 202 SER G 203 ARG K 187 SITE 2 AC9 5 GLY L 66 CRYST1 43.070 70.335 74.197 72.32 86.08 86.02 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023218 -0.001615 -0.001159 0.00000 SCALE2 0.000000 0.014252 -0.004488 0.00000 SCALE3 0.000000 0.000000 0.014163 0.00000